Cannasat Therapeutics Inc. Announces Favourable Decision From United States Patent and Trademark Office

SANTA CLARA, Calif. & WASHINGTON--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE:A) and Anderson Forschung Group LLC (AFG) today announced a collaboration to develop quantitative peptide assays to speed protein biomarker discovery and validation.

Back to news